Clinical Trials in Nashville

Showing 2721-2740 of 20,298 trials

Study of Axicabtagene Ciloleucel Given With Steroids In Participants With Relapsed Or Refractory Large B-Cell Lymphoma

NCT05459571

The goal of this clinical study is to learn more about the study drug, axicabtagene ciloleucel, in participants with relapsed or refractory large B-cell lymphoma (LBCL) in the outpatient setting.

Relapsed or Refractory Large B-cell Lymphoma

Kite, A Gilead Company35 participantsStarted Aug 2022

Duarte, California, United States • Los Angeles, California, United States • Denver, Colorado, United States +13 more locations

Active Not RecruitingPhase 3< 1 mile

Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic nHCM

NCT06081894

This clinical trial will study the effects of aficamten (versus placebo) on the quality of life, exercise capacity, and clinical outcomes of patients with non-obstructive hypertrophic cardiomyopathy.

Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy

Cytokinetics500 participantsStarted Aug 2023

Birmingham, Alabama, United States • La Jolla, California, United States • Los Angeles, California, United States +177 more locations

Study of Axicabtagene Ciloleucel Given With Steroids In Participants With Relapsed Or Refractory Large B-Cell Lymphoma

Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic nHCM

Find Trials by Condition in Nashville

EBUS-TBNA vs Transbronchial Mediastinal Cryobiopsy for Adequacy of Next Generation Sequencing

PO vs IV Antibiotics for the Treatment of Infected Nonunion of Fractures After Fixation

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

A Study of PRT3789 in Combination With Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation

A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis

Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3

Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy

A Weight Loss Study Evaluating Subcutaneous Treatment With AZD9550 and AZD6234 in Combination Against Placebo or Each of the Drugs Alone

Evaluation of Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Stones, A Pivotal Trial

Congenital Heart Disease GEnetic NEtwork Study (CHD GENES)

Phase 3 Randomized, Modified Double-blind, Active-controlled Safety Study on vYF in Adults

A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia

Phase 3 Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary Bypass

Testing the Addition of the Anti-cancer Viral Therapy Telomelysin™ to Chemoradiation for Patients With Advanced Esophageal Cancer and Are Not Candidates for Surgery

Technology Assisted Collaborative Care Intervention to Improve Patient-centered Outcomes in Dialysis Patients

Clinical Trial of Green Tea Catechins in Men on Active Surveillance

A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer

Gene Transfer Study in Patients With Late Onset Pompe Disease